Skip to main content

Table 3 Trends of treatment outcomes, treatment regimens and pulmonary tuberculosis patients type of patients in Anqing, China, 2005–2013 (n = 22,998)

From: Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and negative tuberculosis patients in Anqing, China: a retrospective study

Variables

2005 (n = 1631)

2006 (n = 1576)

2007 (n = 1870)

2008 (n = 3267)

2009 (n = 3134)

2010 (n = 3499)

2011 (n = 2739)

2012 (n = 2861)

2013 (n = 2421)

Successful

1543 (94.60)

1484 (94.16)

1799 (96.20)

3111 (95.22)

2992 (95.47)

3307 (94.51)

2619 (95.62)

2708 (94.65)

2288 (94.51)

 Cured

1439 (88.23)

1255 (79.63)

1248 (66.74)

2350 (71.93)

2107 (67.23)

2106 (60.19)

1572 (57.39)

1052 (36.77)

874 (36.10)

 Treatment completed

104 (6.38)

229 (14.53)

551 (29.47)

761 (23.29)

885 (28.24)

1201 (34.32)

1047 (38.23)

1656 (57.88)

1414 (58.41)

Unsuccessful

88 (5.40)

92 (5.84)

71 (3.80)

156 (4.78)

142 (4.53)

192 (5.49)

120 (4.38)

153 (5.35)

133 (5.49)

 Failure

18 (1.10)

12 (0.76)

6 (0.32)

12 (0.37)

20 (0.64)

26 (0.74)

6 (0.22)

10 (0.35)

16 (0.66)

 Death

22 (1.35)

14 (0.89)

14 (0.75)

18 (0.55)

16 (0.51)

21 (0.60)

18 (0.66)

18 (0.63)

16 (0.66)

 Default

4 (0.25)

10 (0.63)

7 (0.37)

41 (1.25)

38 (1.21)

70 (2.00)

47 (1.72)

58 (2.03)

55 (2.27)

 Transferred out

44 (2.70)

56 (3.55)

44 (2.35)

85 (2.60)

68 (2.17)

75 (2.14)

49 (1.79)

67 (2.34)

46 (1.90)

Regimens

 Regimen 1a

1631

1576

1870

2864 (87.66)

3005 (95.88)

3448 (98.54)

1837 (67.07)

692 (24.19)

658 (27.18)

 Regimen 2b

0

0

0

403 (12.34)

129 (4.12)

51 (1.46)

902 (32.93)

2169 (75.81)

1763 (72.82)

Patients type

 PTB+

1526 (93.56)

1348 (85.53)

1298 (69.41)

2488 (76.16)

2203 (70.29)

2252 (64.36)

1660 (60.61)

1128 (39.43)

939 (38.79)

 PTB-

105 (6.44)

228 (14.47)

572 (30.59)

779 (23.84)

931 (29.71)

1247 (35.64)

1079 (39.39)

1733 (60.57)

1482 (61.21)

  1. PTB+: Smear-positive pulmonary tuberculosis patients
  2. PTB-: Smear-negative pulmonary tuberculosis patients
  3. a2H3R3Z3E3/4H3R3. R = rifampicin; H = isoniazid; Z = pyrazinamide; E = ethambutol. It means once-every-other-day HRZE for 2 months followed by 4 months of once-every-other-day HR
  4. b2HRZE/4HR. It means daily HRZE for 2 months followed by 4 months of daily HR